Withdrawal time estimation of veterinary drugs: extending the range of statistical methods

In order to use a drug in a food producing animal, evidence has to be provided that after a certain withdrawal time, drug residues in tissues, such as muscle meat, fat, liver, kidney etc., are below a given maximum residue limit (MRL), for a majority of animals. Several statistical methods, both regression based and nonparametric based methods, have been proposed, each relying on different sets of assumptions, which may or may not hold for the specific data situation. The purpose of this paper is to enrich the range of methods, i.e. to provide approaches for situations where current methods are inappropriate. Bayesian methods, using Markov chain Monte Carlo, are proposed to derive inference on the parameters of interest.     

The use of pulse oximetry in clinical veterinary anaesthesia

A commercial human pulse oximeter was used in several species to measure heart rate and arterial oxygen saturation (SaO₂), and the results compared with those from an ECG and bench oximeter. The heart rates were always the same, but differences in the SaO₂ ranged between 4.2 per cent to 10.3 per cent. Correlation coefficients between the two SaO₂ measurement techniques ranged from 0.81 to 0.94, depending on the species investigated.     

兽医临床正确应用氨基糖甙类抗生素要点

目前，兽医临床上常用的氨基甙类抗生素有链霉素、新霉素、卡那霉素、庆大霉素、庆大一小诺霉素等。     

Cephalosporins – pharmacological basis of clinical use in veterinary dermatology

Cephalosporins form a large group of β-lactam antibiotics which are used extensively in human medicine and to a lesser extent in domestic animals. In veterinary dermatology, the principle use for the cephalosporins is the clinical management of canine pyoderma associated with Staphylococcus intermedius . In practice, the use of orally administered first generation cephalosporin drugs to affected dogs is well tolerated and highly efficacious. Bacterial drug resistance appears to occur rarely.     

Tocolytic drugs for use in veterinary obstetrics

The author presents a literature review of two tocolytic agents used in veterinary obstetrics: isoxsuprine and clenbuterol. The medical background from which these drugs emerged for human use and to which is linked their application in animal medicine is described. Each drug is reviewed according to its pharmacology, basic considerations for its clinical use and the reports on its application in the treatment and management of obstetrical disorders in veterinary medicine.     

Molecular genetic methods in the veterinary clinical bacteriology laboratory: current usage and future applications

In the last 5 years, numerous molecular methods have been published for the detection and characterization of bacteria in the field of veterinary medicine. PCR has been the most commonly used technology. Although not currently used for clinical veterinary diagnosis, new technologies such as liquid-phase hybridization, real-time PCR, pathogen load determination and DNA/protein microarray have been described and have many possible applications in the clinical bacteriology laboratory because of their sensitivity and efficiency. This review describes the basic principles and application of recently published DNA-based molecular techniques for the purpose of veterinary clinical bacteriological diagnosis. It covers advances in probe hybridization technology, DNA/RNA amplification techniques and other molecular detection methods, including 16S rRNA analysis for bacterial characterization and DNA microarrays for bacterial detection. The review briefly summarizes the application of molecular methods for the diagnosis of specific important bacterial infections of animals, and for other animal pathogens that are slow or difficult to isolate in the clinical bacteriology laboratory. In addition, the molecular detection of antimicrobial resistance genes and of bovine mastitis pathogens is briefly described and current commercially available tests are listed.     

Cephalexin: interpretation of sensitivity disc testing in veterinary practice

A regression study using 30 micrograms cephalexin sensitivity discs with bacterial strains isolated from veterinary sources is described. Techniques suitable for use in veterinary investigation laboratories were used and critical zone sizes calculated from a linear regression analysis. Zone sizes of less than or equal to 18 mm, 19 to 20 mm and greater than or equal to 21 mm were found to be suitable to categorise strains as resistant, intermediate or sensitive, respectively. Experience in the use of these recommended critical zone sizes in clinical practice will be necessary before firm recommendations can be made.     

Economic decisions in veterinary practice: a method for field use

A technique is presented that allows economic decision analysis, sensitivity analysis, and threshold analysis to be done rapidly in field situations. The method allows the practitioner to choose between 2 interventions with different costs and different probabilities of success. A graphic approach is presented, which speeds and simplifies the analysis.     

Production of viral vaccines for veterinary use

This review provides inside information on the production of vaccines for veterinary use. The vaccines against rinderpest as well as foot and mouth disease are considered milestones in the history of veterinary vaccine production. Modern vaccines are based on the scientific progress in virology, cell biology and immunology. While naturally occurring attenuated viruses or viruses obtained after passage in different animal species or cell culture were used as vaccine strains in the early vaccines, nowadays targeted mutagenesis can be applied to generate vaccine virus strains. In principle, the antigen production process is the same for live and inactivated vaccines. The vaccine virus is usually grown in cell culture, either in roller bottles or bioreactors. Most live vaccines are freeze-dried in order to enable storage in the refridgerator for a longer period. To this end, a so-called stabilizer is added to the culture medium. The inactivation of the vaccine virus for the production of killed vaccines is done by physical or chemical treatments that lead to denaturation of the proteins or damage of the nucleic acids. The inactivated antigen may be further purified and mixed with an adjuvant. The quality standards for vaccines are layed down in international regulations and laws. Numerous tests are performed during the different production steps and on the final product in order to warrant the quality of each batch.     

Sulphonamides: updates on use in veterinary medicine

Sulphonamides are the oldest class of antimicrobials and are still the drug of choice for many diseases in veterinary patients. They are classified based on their pharmacokinetics and pharmacodynamics. This article presents an overview of various sulphonamides in each classification, the mechanisms of bacterial resistance, and the effectiveness and maintenance of skin concentrations. Clinical indications, routes and frequency of administration, duration of therapy, compliance factors, cost, adverse drug reactions and drug interactions are described. Controversial topics such as current usage and recommendations for sulphonamide use in dermatology are also discussed.     

Effective use of simulations for the teaching and acquisition of veterinary professional and clinical skills

Simulation technology will feature prominently in this exciting, yet challenging, time for veterinary medicine. The profession is evolving to keep pace with rapid changes in clinical practice, scientific discovery, and educational strategy, while ensuring that it follows the public mandate to produce competent veterinarians. Among the challenges to meeting this educational goal are limitations-due to important issues such as animal welfare-on the availability of real patients for training. Drawing chiefly on the experience in human medicine, this article explores the use of simulations in veterinary medical education to provide safe and ethical alternative opportunities for learners to practice essential clinical and professional skills.     

Cancer antigen 15/3: possible diagnostic use in veterinary clinical oncology. Preliminary study

The cancer antigen 15/3 is a mucin that is associated with the cell membrane, encoded by the MUC1 gene, and recognized by the monoclonal-clone DF3 antibody. The latter antigen was discovered to be specific for both the identification of human mammary neoplasia and during patient follow-up evaluations. The aim of this study is to report and compare the results of the application of direct chemiluminescence in canine blood sera and the kit utilized in human medicine for the determination of Ca 15/3 to verify the diagnostic efficiency of the kit in cases presenting mammary tumors. Specifically, CA 15/3 has proven to be measurable in all samples assayed to distinguish clinically healthy subjects from those with mammary neoplasia.

     

Model of bacteriologic effectiveness testing of disinfectants for veterinary medicine

Proper evaluation of effectiveness of chemical disinfectants depends on availability of a standardised test methodology which can provide reproducible values. The binding rules and regulations for testing and acceptance under the heading of "Methods for Testing Chemical Disinfectants for Veterinary Medicine" (team of authors, 1987) have resulted from years of experimental research in the field of disinfectant development. They include a model for bacteriological laboratory testing which is described in this paper, with complementary reference being made to experimental planning and appraisal of disinfection success. An account is given of preparatory testing, using agar diffusion and serial dilution tests, and of main testing, using suspension and microorganism carrier tests. The RF% microorganism reduction rate is introduced for appraisal of disinfection success. With differentiated initial germ counts, the comparability of experimental results provided by RF% has proved to be superior to that obtainable from conventional calculation.